---

Nigerian pharmaceutical company Fidson Healthcare Plc has inked a Strategic Cooperation Memorandum with Chinese firms Jiangsu Aidea Pharma, Nanjing PharmaBlock, and the China-Africa Development Fund centered around the fight against a big continental scourge: HIV and AIDS.

The World Health Organization estimates that there are an estimated 25.6 million people living with HIV in the African region, claiming an estimated 380,000 lives from AIDS-related illnesses in 2022.

To this date, the disease is still a cause of many avoidable deaths, with a huge population still struggling to gain access to life-saving antiretroviral (ARV) medication.

---

READ ALSO: How to boost pharmaceutical manufacturing in Africa

---

This is why this agreement is monumental, as it is well-positioned to support Africa's independence in providing healthcare, particularly in the fight against HIV.

The four parties to the collaboration have decided to actively use their unique strengths to develop a new joint venture pharmaceutical plant project in Nigeria as a result of this collaboration.

Consequently, they have agreed to pool resources and knowledge, look together for potential investments in West African pharmaceutical markets, and carry out project-level investment collaboration.

“We eagerly look forward to this collaboration and believe that the complementary strengths of all parties will inject new vitality into the healthcare delivery sector in Africa, particularly addressing the medical needs of over 1.9 million HIV-infected individuals in Nigeria, a focus of Aidea Pharma,” said

 

Dr. Fidelis Ayebae, the founder and MD of Fidson Healthcare Plc.

According to Fidson Healthcare Plc, the planned production facility will become a center for “pharmaceutical excellence,” leveraging the strategic location and extensive infrastructure of the Lekki Free Trade Zone.

“This collaboration marks an important step for Chinese pharmaceutical players in their commitment to global medical cooperation. By integrating our expertise and experience in the field of innovative drugs, we are confident in bringing greater well-being to African patients,” stated Dr. Heliang Fu, Chairman of Jiangsu Aidea Pharma.

---

Did you find this insightful? Subscribe for more.

---